BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29102263)

  • 1. Gender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trial.
    Chow R; Ding K; Ganesh V; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; van Acht M; Wanders R; Babington S; Demas WF; Wilson CF; Wong RKS; Brundage M; Zhu L; Chow E
    Radiother Oncol; 2018 Mar; 126(3):541-546. PubMed ID: 29102263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC-Twenty-Three Randomized Trial.
    Chow S; Ding K; Wan BA; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chow E
    Am J Hosp Palliat Care; 2018 Apr; 35(4):718-723. PubMed ID: 28950727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in pain and patient reported outcomes: a secondary analysis of the NCIC CTG SC. 23 randomized trial.
    Chow S; Ding K; Wan BA; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chow E
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S185-S194. PubMed ID: 29156903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23.
    McDonald R; Ding K; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chan S; Chow E
    JAMA Oncol; 2017 Jul; 3(7):953-959. PubMed ID: 28196208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
    Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trial.
    Chow E; Meyer RM; Chen BE; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JS; Nabid A; Tissing-Tan CJ; Oei B; Babington S; Demas WF; Wilson CF; Wong RK; Brundage M
    J Clin Oncol; 2014 Dec; 32(34):3867-73. PubMed ID: 25349296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-irradiation for painful bone metastases using stereotactic body radiotherapy.
    Ogawa H; Ito K; Shimizuguchi T; Furuya T; Nihei K; Karasawa K
    Acta Oncol; 2018 Dec; 57(12):1700-1704. PubMed ID: 30280622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Net Pain Relief After Palliative Radiation Therapy for Painful Bone Metastases: A Useful Measure to Reflect Response Duration? A Further Analysis of the Dutch Bone Metastasis Study.
    Spencer K; Velikova G; Henry A; Westhoff P; Hall PT; van der Linden YM
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):559-566. PubMed ID: 31344434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-irradiation for painful bone metastases: evidence-based approach.
    Chiu N; Chiu L; Popovic M; DeAngelis C; Lutz S; Zhang N; Marta GN; Mendez LC; Lechner B; Pulenzas N; Milakovic M; Chow R; Chow E
    Ann Palliat Med; 2015 Oct; 4(4):214-9. PubMed ID: 26541401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative Reirradiation for Painful Bone Metastases: Clinical Cases and Literature Review.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Tatekawa K; Shimizu D; Kimoto T; Nishimura T; Nakashima A; Yamada K
    Kurume Med J; 2018 Feb; 64(1.2):5-11. PubMed ID: 29249780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET).
    Mercier C; Dirix P; Ost P; Billiet C; Joye I; Vermeulen P; Lievens Y; Verellen D
    BMC Cancer; 2019 Sep; 19(1):876. PubMed ID: 31484505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.
    Chow E; Meyer RM; Ding K; Nabid A; Chabot P; Wong P; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; Brundage M; DeAngelis C; Wong RKS
    Lancet Oncol; 2015 Nov; 16(15):1463-1472. PubMed ID: 26489389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy for osseous low alpha-beta resistant metastases for pain relief-SOLAR-P.
    Nguyen EK; Quan K; Parpia S; Tran S; Swaminath A
    Radiat Oncol; 2021 Sep; 16(1):170. PubMed ID: 34479581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.
    Zeng L; Chow E; Bedard G; Zhang L; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e337-42. PubMed ID: 22763028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the effectiveness of combined radiotherapy and hyperthermia for the treatment response of patients with painful bony metastases: A phase 2 clinical trial.
    Ariyafar T; Mahdavi SR; Geraily G; Fadavi P; Farhood B; Najafi M; Ashouri A; Khalafi L; Shirazi A
    J Therm Biol; 2019 Aug; 84():129-135. PubMed ID: 31466745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated radiotherapy for complicated bone metastases in patients with poor performance status: a phase II international trial.
    Silva MF; Marta GN; Lisboa FPC; Watte G; Trippa F; Maranzano E; da Motta NW; Popovic M; Ha T; Burmeister B; Chow E
    Tumori; 2019 Apr; 105(2):181-187. PubMed ID: 28665472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic biomarkers associated with changes in quality of life and pain following palliative radiotherapy in patients with bone metastases.
    Furfari A; Wan BA; Ding K; Wong A; Zhu L; Bezjak A; Wong R; Wilson CF; DeAngelis C; Azad A; Chow E; Charames GS
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S248-S256. PubMed ID: 29156910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of re-irradiation for painful bone metastases on urinary markers of osteoclast activity (NCIC CTG SC.20U).
    Chow E; DeAngelis C; Chen BE; Azad A; Meyer RM; Wilson C; Kerba M; Bezjak A; Wilson P; Nabid A; Greenland J; Rees G; Vieth R; Wong RK; Hoskin P
    Radiother Oncol; 2015 Apr; 115(1):141-8. PubMed ID: 25782738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
    Radiother Oncol; 2016 May; 119(2):208-12. PubMed ID: 27157890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A consensus development approach to define national research priorities in bone metastases: proceedings from NCIC CTG workshop.
    Wu J; Bezjak A; Chow E; Cross P; Genest P; Grant N; Kirkbride P; Roy I; Whelan T; Fitzgibbon E; Wong R
    Clin Oncol (R Coll Radiol); 2003 Dec; 15(8):496-9. PubMed ID: 14690007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.